Evidence map›Paper›PMID 32393600›Full record

ArticleJournal of cell science2020

AURKA destruction is decoupled from its activity at mitotic exit but is essential to suppress interphase activity.

Ahmed Abdelbaki, H Begum Akman, Marion Poteau, Rhys Grant, Olivier Gavet, Giulia Guarguaglini, Catherine Lindon

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. A single-cell atlas of thebioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The Multifaceted Regulation of Mitochondrial Dynamics During Mitosis.Frontiers in cell and developmental biology · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Ahmed AbdelbakiDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.
H Begum AkmanDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.
Marion PoteauInstitut Gustave Roussy, UMR9019 - CNRS, 114 rue Edouard Vaillant, 94805 Villejuif, France.
Rhys GrantDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK.ORCID 0000-0003-4027-0972
Olivier GavetInstitut Gustave Roussy, UMR9019 - CNRS, 114 rue Edouard Vaillant, 94805 Villejuif, France.ORCID 0000-0003-3671-2942
Giulia GuarguagliniInstitute of Molecular Biology and Pathology, CNR, Via degli Apuli 4, 00185 Roma, Italy.ORCID 0000-0002-7541-8183
Catherine LindonDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK acl34@cam.ac.uk.ORCID 0000-0003-3554-2574
University of Cambridge · GBCentre National de la Recherche Scientifique · FRInstitute of Molecular Biology and Pathology · IT

Funding

Biotechnology and Biological Sciences Research Council BB/R004137/1Medical Research Council MR/M01102X/1
6 · The paper itself

Abstract

Activity of AURKA is controlled through multiple mechanisms including phosphorylation, ubiquitin-mediated degradation and allosteric interaction with TPX2. Activity peaks at mitosis, before AURKA is degraded during and after mitotic exit in a process strictly dependent on the APC/C coactivator FZR1. We used FZR1 knockout cells (FZR1

Indexed as

Aurora Kinase ACell Cycle ProteinsAnaphase-Promoting Complex-CyclosomeInterphaseMitosisUbiquitin-Protein Ligase ComplexesAnaphase-Promoting Complex-CyclosomeAurora Kinase ACell Cycle ProteinsUbiquitin-Protein Ligase ComplexesAurora A kinaseCdh1FZR1MitochondriaMitosisTPX2

Identifiers

PMID32393600
PMCPMC7328152
OpenAlexW3021650619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.